Monitoring antibiotic concentrations is challenging with traditional affinity reagents, especially for small molecule targets. This limitation has restricted research and diagnostic potential in the field. Optimers can be generated to small molecule hapten targets easily for use on a range of platforms.

Download our application note to discover how one of partner companies is integrating Optimer technology for antibiotic targets into their rapid diagnostic platform to revolutionize how we treat infections.

This application note demonstrates

• the excellent selectivity of Optimer reagents developed to the moxifloxacin antibiotic target.
• how Optimers are being incorporated into a rapid biosensor diagnostic platform to detect moxifloxacin across the clinical concentration range.
• maintenance of the performance of the Optimer-based biosensor in a complex human serum matrix.
• how this platform can be adapted to offer rapid diagnostic solutions for a range of biomarkers and disease conditions.

Read our interview with QSM Diagnostics

Tags